GHAM
TMO icon

Gilman Hill Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Gilman Hill Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.89M Buy
11,754
+3,386
+40% +$1.63M 0.81% 51
2026
Q1 		$4.11M Buy
8,368
+365
+5% +$198K 0.62% 68
2025
Q4 		$4.64M Buy
8,003
+897
+13% +$507K 0.73% 65
2025
Q3 		$3.45M Buy
7,106
+178
+3% +$82.9K 0.54% 75
2025
Q2 		$2.81M Buy
6,928
+125
+2% +$52.3K 0.46% 76
2025
Q1 		$3.39M Buy
6,803
+48
+0.7% +$26K 0.59% 67
2024
Q4 		$3.51M Buy
6,755
+273
+4% +$150K 0.61% 65
2024
Q3 		$4.01M Buy
6,482
+46
+0.7% +$27.2K 0.67% 58
2024
Q2 		$3.56M Buy
6,436
+79
+1% +$45.3K 0.64% 65
2024
Q1 		$3.69M Buy
6,357
+33
+0.5% +$18.5K 0.66% 59
2023
Q4 		$3.36M Sell
6,324
-23
-0.4% -$11.1K 0.62% 58
2023
Q3 		$3.21M Buy
6,347
+148
+2% +$78.9K 0.63% 57
2023
Q2 		$3.23M Buy
6,199
+169
+3% +$91.2K 0.6% 60
2023
Q1 		$3.48M Buy
6,030
+395
+7% +$223K 0.71% 53
2022
Q4 		$3.1M Buy
5,635
+958
+20% +$508K 0.64% 54
2022
Q3 		$2.37M Sell
4,677
-67
-1% -$37.5K 0.55% 58
2022
Q2 		$2.58M Buy
4,744
+559
+13% +$308K 0.55% 53
2022
Q1 		$2.47M Buy
4,185
+478
+13% +$275K 0.56% 60
2021
Q4 		$2.47M Sell
3,707
-75
-2% -$46.8K 0.55% 57
2021
Q3 		$2.16M Buy
3,782
+35
+0.9% +$19.2K 0.55% 62
2021
Q2 		$1.89M Buy
3,747
+826
+28% +$390K 0.48% 65
2021
Q1 		$1.33M Buy
2,921
+533
+22% +$254K 0.37% 76
2020
Q4 		$1.11M Buy
2,388
+148
+7% +$69.4K 0.36% 80
2020
Q3 		$989K Sell
2,240
-190
-8% -$78.5K 0.38% 72
2020
Q2 		$880K Sell
2,430
-8
-0.3% -$2.68K 0.35% 77
2020
Q1 		$691K Buy
+2,438
New +$769K 0.34% 85

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Gilman Hill Asset Management's TMO Position: Q2 2026 in Review

Gilman Hill Asset Management increased its Thermo Fisher Scientific (TMO) stake by 40% in Q2 2026, buying an estimated $1.63M and bringing the position to 11,754 shares worth $5.89M. The position accounts for 0.81% of the portfolio, ranked #51.

Gilman Hill Asset Management first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Gilman Hill Asset Management held 11,754 shares of Thermo Fisher Scientific worth $5.89M as of Q2 2026.
  • Gilman Hill Asset Management bought 3,386 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.63M.
  • Thermo Fisher Scientific made up 0.81% of Gilman Hill Asset Management's portfolio in Q2 2026, its #51 holding.
  • Gilman Hill Asset Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Gilman Hill Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.